Skip to main content
. 2021 May 28;22:200. doi: 10.1186/s12882-021-02400-3

Table 2.

Incidence Rates per 1000 person years (95% confidence intervals) for outcomes during up to 8 years follow up in adults with or without acute kidney injury (AKI), stratified by body mass index

BMI category
< 20 kg/m2 20–24.9 kg/m2 25–29.9 kg/m2 ≥ 30 kg/m2
Incident CKD (n = 201 events)
 No AKI
  Events/total n 2/15 7/75 28/164 29/209
  Rate 31.5 (7.9 to 125.8) 20.0 (9.5 to 42.0) 35.7 (24.7 to 51.7) 29.7 (20.6 to 42.7)
 AKI
  Events 2/11 23/85 30/134 80/233
  Rate 57.6 (14.4 to 230) 71.4 (47.5 to 108) 56.2 (39.3 to 80.3) 94.4 (75.8 to 118)
CKD Progression (n = 64 events)
 No AKI
  Events 1/6 1/50 7/105 11/145
  Rate 44.9 (6.2 to 320) 4.6 (0.6 to 32.6) 14.8 (7.1 to 31.1) 18.4 (10.2 to 33.2)
 AKI
  Events 0/5 9/49 11/89 24/163
  Rate 0 47.1 (24.5 to 90.5) 32.7 (18.1 to 59.1) 38.7 (25.9 to 57.7)
ESRD (n = 58 events)
 No AKI
  Events 2/21 2/125 2/269 6/354
  Rate 24.0 (6.0 to 96.1) 3.5 (0.9 to 13.8) 1.5 (0.4 to 8.1) 3.6 (1.6 to 8.1)
 AKI
  Events 0/16 7/134 13/223 26/396
  Rate 0 12.4 (5.9 to 26.1) 13.7 (8.0 to 23.6) 15.5 (10.5 to 22.7)
Combined CKD event (n = 300 events)
 No AKI
  Events 4/21 10/125 36/269 43/354
  Rate 49.0 (18.4 to 130) 17.7 (9.5 to 33.0) 28.7 (20.7 to 39.7) 27.4 (20.3 to 36.9)
 AKI
  Events 2/16 36/134 48/223 121/396
  Rate 39.0 (9.7 to 155.9) 72.6 (52.3 to 101) 56.4 (42.5 to 74.8) 84.7 (70.9 to 101)
Major Atherosclerotic Cardiovascular Events (MACE n = 129 events)
 No AKI
  Events 2/21 13/125 26/269 28/354
  Rate 24.1 (6.0 to 96.4) 24.3 (14.1 to 41.9) 22.0 (15.0 to 32.3) 18.5 (12.8 to 26.8)
 AKI
  Events 2/21 8/134 25/223 25/396
  Rate 37.8 (9.5 to 151.2) 15.2 (7.6 to 30.5) 28.1 (19.0 to 41.6) 15.4 (10.4 to 22.9)
Death (n = 320 events)
 No AKI
  Events 5/21 18/125 39/269 50/354
  Rate 56.0 (23.3 to 135) 30.9 (19.5 to 49.0) 29.7 (21.7 to 40.6) 30.0 (22.8 to 39.6)
 AKI
  Events 11/16 38/134 60/223 99/396
  Rate 196.5 (109 to 355) 64.9 (47.2 to 89.2) 60.8 (47.2 to 78.4) 56.9 (46.7 to 69.3)